RNTX Rein Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$0.80
· of 52w range
· above low
· to high
$0.6952w low
$2.1852w high
Market Cap (MRQ)
$69M
P/E (TTM)
-0.5
EPS (TTM)
$-1.72
Revenue (TTM)
$0
your badges
52W Range
$1–$2
Analyst Rating
BUY
Price Target
$6
P/E
-0.5
ROE
-96.4%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
RNTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.80
Market Cap (MRQ)
$69M
P/E (TTM)
-0.5
EPS (TTM)
$-1.72
Revenue (TTM)
$0
ROE (TTM)
-96.4%
52W Range
$1–$2
RNTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Nov. 11, 2022 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02016-12-31 → 2025-12-31
EPS$-1.962021-12-31 → 2025-12-31
Free Cash Flow·2017-12-31 → 2021-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | RNTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -0.55Y avg ≈-0.9 | ≈-0.9 | · | · | |
| P/B (MRQ) | 1.2 | · | 2.9 | Undervalued | |
| Price / Tangible Book (MRQ) | 1.65Y avg ≈8.4 | ≈8.4 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | RNTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA (TTM) | -80.6% | · | -46.2% | Weak | |
| ROE (TTM) | -96.4% | · | -66.8% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | RNTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.3 | · | 5.3 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | RNTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-250.8%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $-0.10 | $-0.17 | 42.3% |
| March 31, 2026 | May 15, 2026 | $-0.19 | $-0.50 | 62.0% |
| Dec. 31, 2025 | $-1.09 | $-0.22 | -398.1% | |
| Sept. 30, 2025 | $-0.21 | $-0.24 | 14.2% | |
| June 30, 2025 | $-0.28 | $-0.22 | -24.8% | |
| March 31, 2025 | $-0.25 | $-0.25 | -0.04% | |
| Dec. 31, 2024 | $-2.20 | $-0.14 | -1451.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $11M | $14M | $4M | $18M | $17M | $11M | $18M | $18M | $14M | $10M | |
| SG&A Expense | $11M | $14M | $11M | $10M | $10M | $9M | $12M | $13M | $9M | $8M | |
| Operating Expenses | $51M | $65M | $16M | $28M | $27M | $20M | $30M | $32M | $23M | $18M | |
| Operating Income | $-51M | $-65M | $-16M | $-28M | $-27M | $-20M | $-30M | $-32M | $-23M | $-18M | |
| Other Non-op | $48.0K | $685.0K | $544.0K | $318.0K | $441.0K | $-661.0K | $587.0K | · | · | · | |
| Income Tax | $-712.0K | $-2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-50M | $-63M | $-16M | $-27M | $-26M | $-27M | $-29M | $-32M | $-23M | $-18M | |
| EPS (Basic) | $-1.96 | $-3.51 | $-3.42 | $-6.02 | $-5.89 | · | · | · | · | · | |
| EPS (Diluted) | $-1.96 | $-3.51 | $-3.42 | $-6.02 | $-5.89 | · | · | · | · | · | |
| Shares (Basic) | 25,444,795 | 17,938,899 | 4,598,715 | 4,539,318 | 4,440,338 | · | · | · | · | · | |
| Shares (Diluted) | 25,444,795 | 17,938,899 | 4,598,715 | 4,539,318 | 4,440,338 | · | · | · | · | · | |
| EBITDA | · | · | · | · | $-26M | $-20M | $-30M | · | $-23M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $13M | $17M | $5M | $4M | $7M | $5M | $11M | $12M | $21M | |
| Short-term Investments | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $792.0K | $882.0K | $606.0K | $2M | $2M | $1M | $1M | $1M | $333.0K | |
| Other Current Assets | $881.0K | $676.0K | $675.0K | $606.0K | · | · | · | · | · | · | |
| Current Assets | $4M | $14M | $18M | $22M | $48M | $16M | $20M | $22M | $52M | $21M | |
| PP&E (Net) | $0 | $1.0K | $19.0K | $70.0K | $128.0K | $15.0K | $295.0K | $7M | $154.0K | $107.0K | |
| PP&E (Gross) | · | · | $377.0K | $340.0K | $340.0K | $181.0K | $817.0K | $8M | $2M | $2M | |
| Accum. Depreciation | · | · | $358.0K | $270.0K | $212.0K | $166.0K | $522.0K | $1M | $2M | $2M | |
| Goodwill | $6M | $6M | $6M | · | · | · | · | · | · | · | |
| Intangibles | $14M | $42M | $79M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2.0K | $2.0K | $2M | $24.0K | $24.0K | · | · | $679.0K | $694.0K | $778.0K | |
| Total Assets | $24M | $62M | $106M | $22M | $48M | $16M | $26M | $30M | $53M | $22M | |
| Accounts Payable | $4M | $911.0K | $1M | $2M | $1M | $2M | $1M | $2M | $2M | $2M | |
| Short-term Debt | $0 | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $6M | $6M | $4M | $3M | $5M | $4M | $6M | $5M | $5M | $4M | |
| Capital Leases | · | · | · | · | $69.0K | · | $5M | · | · | · | |
| Deferred Tax | $1M | $2M | $3M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $0 | $277.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $7M | $8M | $8M | $3M | $5M | $4M | $10M | $11M | $5M | $4M | |
| Common Stock | $113.0K | $108.0K | $91.0K | $91.0K | $91.0K | $44.0K | $28.0K | $15.0K | $15.0K | $0 | |
| Retained Earnings | $-401M | $-351M | $-289M | $-273M | $-245M | $-219M | $-198M | $-168M | $-137M | $-114M | |
| AOCI | $-62.0K | $-18.0K | $-63.0K | $-48.0K | $-13.0K | $-2.0K | $7.0K | $-5.0K | $-33.0K | · | |
| Stockholders' Equity | $17M | $54M | $98M | $19M | $44M | $12M | $16M | $20M | $48M | $-112M | |
| Liabilities + Equity | $24M | $62M | $106M | $22M | $48M | $16M | $26M | $30M | $53M | $22M | |
| Shares Outstanding | 27,550,222 | 21,666,012 | 4,885,512 | 4,541,167 | 4,528,667 | 2,190,208 | 27,810,358 | 14,748,475 | 14,723,818 | 432,413 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.0K | $63.0K | $119.0K | $169.0K | $121.0K | $163.0K | $155.0K | $218.0K | $129.0K | $232.0K | |
| Stock-based Comp | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $688.0K | |
| Deferred Tax | $-712.0K | $-2M | $0 | · | · | · | · | · | · | · | |
| Restructuring | · | $0 | $928.0K | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | $29.0K | $-1M | $624.0K | · | $195.0K | · | |
| Operating Cash Flow | $-19M | $-22M | $-20M | $-25M | $-24M | $-20M | $-26M | $-28M | $-21M | $-15M | |
| CapEx | · | · | · | · | $157.0K | $5.0K | $151.0K | $4M | $142.0K | · | |
| Investing Cash Flow | · | $0 | $16M | $26M | $-36M | $6M | $-3M | $25M | $-39M | · | |
| Stock Issued | $2M | $11M | $0 | · | · | $17M | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $17M | · | · | · | · | |
| Financing Cash Flow | $10M | $18M | $16M | · | $56M | $16M | $24M | $3M | $51M | · | |
| Net Change in Cash | $-10M | $-4M | $12M | $2M | $-4M | $2M | $-5M | $-723.0K | $-9M | $17M | |
| Free Cash Flow | · | · | · | · | $-24M | $-20M | $-27M | · | $-21M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | · | · | · | -80.7% | -98.8% | -103.4% | · | -60.5% | · | |
| ROE | · | · | · | · | -55.7% | -171.9% | -151.1% | · | 70.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 10.7 | 4.1 | 3.3 | · | 10.6 | · | |
| Quick Ratio | · | · | · | · | 0.8 | 1.8 | 0.9 | · | 2.4 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | $0.48 | $0.28 | $0.58 | · | $3.25 | · | |
| Cash / Share | · | · | · | · | $0.04 | $0.16 | $0.19 | · | $0.81 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-1.96 | $-3.51 | $-3.42 | $-6.02 | $-5.89 | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-50M | $-63M | $-16M | $-27M | $-26M | $-27M | $-29M | $-32M | $-23M | · | |
| Market Cap | · | · | · | · | $1.02B | $911M | $319M | · | $3.10B | · | |
| P/E | -0.6 | -0.7 | -0.9 | -0.4 | -1.9 | · | · | · | · | · | |
| P/B | · | · | · | · | 23.2 | 74.9 | 19.9 | · | 64.9 | · | |
| P / Tangible Book | · | 8.5 | 1.2 | 0.6 | 23.2 | 74.9 | · | · | · | · | |
| P / Cash Flow | · | · | · | · | -42.9 | -44.5 | -12.0 | · | -151.2 | · | |
| P / FCF | · | · | · | · | -42.7 | -44.5 | -12.0 | · | -150.1 | · | |
| Earnings Yield | -169.0% | -152.6% | -112.2% | -254.0% | -52.3% | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $4M | $3M | $2M | $2M | $4M | $3M | $3M | $4M | $4M | $3M | $2M | $22.0K | $187.0K | $2M | $2M | $4M | |
| SG&A Expense | $2M | $2M | $2M | $4M | $3M | $3M | $2M | $2M | $5M | $4M | $5M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $6M | $5M | $33M | $5M | $7M | $6M | $43M | $6M | $9M | $7M | $7M | $2M | $2M | $5M | $5M | $6M | |
| Operating Income | $-6M | $-5M | $-33M | $-5M | $-7M | $-6M | $-43M | $-6M | $-9M | $-7M | $-7M | $-2M | $-2M | $-5M | $-5M | $-6M | |
| Other Non-op | $-299.0K | $-608.0K | $-20.0K | $-89.0K | $49.0K | $108.0K | $272.0K | $224.0K | $97.0K | $92.0K | $-49.0K | $156.0K | $205.0K | $232.0K | $336.0K | $4.0K | |
| Net Income | $-6M | $-6M | $-32M | $-6M | $-7M | $-6M | $-41M | $-6M | $-9M | $-7M | $-7M | $-2M | $-2M | $-5M | $-5M | $-6M | |
| EPS (Basic) | $-0.10 | $-0.19 | $-1.22 | $-0.21 | $-0.28 | $-0.25 | $-1.93 | $-0.27 | $-0.45 | $-0.86 | $-1.58 | $-0.40 | $-0.39 | $-1.05 | $-1.00 | $-1.40 | |
| EPS (Diluted) | $-0.10 | $-0.19 | $-1.22 | $-0.21 | $-0.28 | $-0.25 | $-1.93 | $-0.27 | $-0.45 | $-0.86 | $-1.58 | $-0.40 | $-0.39 | $-1.05 | $-1.00 | $-1.40 | |
| Shares (Basic) | 67,084,661 | 30,354,647 | · | 26,361,386 | 24,187,536 | 21,915,891 | · | 21,663,089 | 19,911,462 | 8,301,798 | · | 4,541,167 | 4,541,167 | 4,541,167 | · | 4,541,179 | |
| Shares (Diluted) | 67,084,661 | 30,354,647 | · | 26,361,386 | 24,187,536 | 21,915,891 | · | 21,663,089 | 19,911,462 | 8,301,798 | · | 4,541,167 | 4,541,167 | 4,541,167 | · | 4,541,179 | |
| EBITDA | $-6M | $-5M | · | $-5M | $-7M | $-6M | · | $-6M | $-9M | $-7M | · | $-2M | $-2M | $-5M | · | $-6M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $3M | $4M | $6M | $7M | $13M | $18M | $22M | $12M | $17M | $12M | $13M | $8M | $5M | $5M | |
| Short-term Investments | $32M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $806.0K | $1M | $1M | $1M | $880.0K | $903.0K | $792.0K | $1M | $1M | $697.0K | $882.0K | $699.0K | $261.0K | $359.0K | $606.0K | $2M | |
| Other Current Assets | $727.0K | $918.0K | $881.0K | $997.0K | $692.0K | $864.0K | $676.0K | $755.0K | $304.0K | $547.0K | $675.0K | · | · | · | $606.0K | · | |
| Current Assets | $41M | $5M | $4M | $5M | $7M | $8M | $14M | $19M | $23M | $13M | $18M | $13M | $14M | $17M | $22M | $27M | |
| PP&E (Net) | · | · | $0 | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $6.0K | $19.0K | $29.0K | $39.0K | $52.0K | $70.0K | $84.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $340.0K | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $295.0K | $285.0K | $272.0K | $270.0K | $256.0K | |
| Goodwill | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | · | · | · | · | · | |
| Intangibles | $14M | $14M | $14M | $42M | $42M | $42M | $42M | $79M | $79M | $79M | $79M | · | · | · | · | · | |
| Other Non-current Assets | $2M | $1M | $2.0K | $2.0K | $2M | $766.0K | $2.0K | $2.0K | $709.0K | $892.0K | $2M | · | · | · | $24.0K | $24.0K | |
| Total Assets | $66M | $26M | $24M | $54M | $57M | $58M | $62M | $104M | $109M | $99M | $106M | $13M | $14M | $17M | $22M | $27M | |
| Accounts Payable | $4M | $6M | $4M | $4M | $6M | $1M | $911.0K | $1M | $782.0K | $2M | $1M | $484.0K | $136.0K | $458.0K | $2M | $945.0K | |
| Short-term Debt | · | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $10M | $14M | $6M | $6M | $8M | $6M | $6M | $6M | $5M | $5M | $4M | $2M | $1M | $3M | $3M | $5M | |
| Deferred Tax | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $277.0K | · | $116.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $11M | $15M | $7M | $8M | $9M | $8M | $8M | $9M | $8M | $8M | $8M | $2M | $1M | $3M | $3M | $5M | |
| Total Debt | · | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $172.0K | $114.0K | $113.0K | $111.0K | $109.0K | $108.0K | $108.0K | $108.0K | $107.0K | $103.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | |
| Retained Earnings | $-413M | $-407M | $-401M | $-369M | $-364M | $-357M | $-351M | $-310M | $-305M | $-296M | $-289M | $-281M | $-279M | $-278M | $-273M | $-268M | |
| AOCI | $-69.0K | $-62.0K | $-62.0K | $-44.0K | $-44.0K | $-32.0K | $-18.0K | $-26.0K | $-22.0K | $-63.0K | $-63.0K | · | $-2.0K | $-10.0K | $-48.0K | $-98.0K | |
| Stockholders' Equity | $55M | $12M | $17M | $46M | $48M | $50M | $54M | · | · | · | $98M | $11M | $13M | $14M | $19M | $23M | |
| Liabilities + Equity | $66M | $26M | $24M | $54M | $57M | $58M | $62M | $104M | $109M | $99M | $106M | $13M | $14M | $17M | $22M | $27M | |
| Shares Outstanding | 85,767,032 | 28,039,032 | 27,550,222 | 25,140,092 | 23,046,121 | 22,005,317 | 21,666,012 | 21,665,941 | 21,625,085 | 16,842,512 | 4,885,512 | 4,541,167 | 4,541,167 | 4,541,167 | 4,541,167 | 90,823,597 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $0 | $1.0K | $0 | $0 | $0 | $4.0K | $59.0K | $52.0K | $12.0K | $12.0K | $43.0K | $43.0K | $43.0K | |
| Stock-based Comp | $164.0K | $156.0K | $257.0K | $1M | $256.0K | $264.0K | $133.0K | $508.0K | $326.0K | $150.0K | $270.0K | $229.0K | $300.0K | $391.0K | $424.0K | $442.0K | |
| Restructuring | · | · | · | · | · | · | · | $0 | $0 | $0 | $-12.0K | $6.0K | $-88.0K | $1M | · | · | |
| Other Non-cash | · | · | · | · | · | $-938.0K | · | · | · | $2M | · | · | · | $-316.0K | · | · | |
| Operating Cash Flow | $-9M | $-3M | $-3M | $-4M | $-6M | $-6M | $-5M | $-4M | $-8M | $-5M | $-10M | $-2M | $-3M | $-5M | $-4M | $-7M | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | $-96.0K | $542.0K | $8M | $7M | $5M | $4M | |
| Stock Issued | $53M | $354.0K | $1M | $0 | $-370.0K | $737.0K | $0 | $-292.0K | $11M | $0 | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $354.0K | · | · | · | $737.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $48M | $5M | $2M | $2M | $5M | $738.0K | $1.0K | $-446.0K | $18M | $0 | $16M | $0 | · | · | · | · | |
| Net Change in Cash | $4M | $1M | $-833.0K | $-2M | $-2M | $-5M | $-5M | $-4M | $10M | $-5M | $5M | $-1M | $5M | $3M | $355.0K | $-3M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.3% | -13.9% | · | -7.1% | -8.2% | -7.0% | · | -10.0% | -14.5% | -12.2% | · | -9.1% | -7.5% | -16.7% | · | -15.5% | |
| ROE | -12.3% | -19.0% | · | -19.4% | -22.4% | -17.2% | · | · | · | · | · | -10.8% | -8.6% | -19.0% | · | -17.5% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 0.4 | · | 0.9 | 0.9 | 1.4 | · | 3.3 | 4.7 | 2.8 | · | 7.9 | 11.7 | 5.9 | · | 6.0 | |
| Quick Ratio | 4.2 | 0.3 | · | 0.7 | 0.7 | 1.2 | · | 3.1 | 4.4 | 2.7 | · | 7.4 | 11.0 | 2.7 | · | 1.1 | |
| Debt / Equity | · | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.64 | $0.41 | · | $1.84 | $2.08 | $2.27 | · | · | · | · | · | $2.47 | $2.82 | $3.14 | · | $0.25 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.11 | · | · | · | $-0.28 | · | · | · | $-0.63 | · | · | · | $-1.03 | · | · | |
| Cash / Share | $0.10 | $0.16 | · | $0.16 | $0.25 | $0.34 | · | $0.81 | $1.01 | $0.71 | · | $2.66 | $2.90 | $1.71 | · | $0.05 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-1.72 | $-1.90 | · | $-2.67 | $-2.73 | $-2.90 | · | $-3.16 | $-3.29 | $-3.23 | · | $-2.84 | $-3.84 | $-5.21 | · | $-10.69 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-50M | $-50M | · | $-59M | $-59M | $-61M | · | $-29M | $-25M | $-18M | · | $-13M | $-17M | $-24M | · | $-30M | |
| Market Cap | $89M | $36M | · | $29M | $32M | $39M | · | $77M | $60M | $112M | · | $7M | $8M | $6M | · | $376M | |
| Enterprise Value | · | $37M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.6 | -0.7 | · | -0.4 | -0.5 | -0.6 | · | -1.1 | -0.8 | -2.1 | · | -0.5 | -0.5 | -0.2 | · | -0.4 | |
| P/B | 1.6 | 3.1 | · | 0.6 | 0.7 | 0.8 | · | · | · | · | · | 0.6 | 0.6 | 0.4 | · | 16.6 | |
| P / Tangible Book | 2.5 | · | · | · | · | 28.9 | · | · | · | · | · | 0.6 | 0.6 | 0.4 | · | 16.6 | |
| P / Cash Flow | · | -10.6 | · | · | · | -6.3 | · | · | · | -21.2 | · | · | · | -1.2 | · | · | |
| Earnings Yield | -165.4% | -146.2% | · | -233.2% | -195.0% | -163.8% | · | -89.3% | -118.8% | -48.7% | · | -186.8% | -214.5% | -420.2% | · | -258.2% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-50M | $-63M | $-16M | $-27M | $-26M |
| Diluted EPS | $-1.96 | $-3.51 | $-3.42 | $-6.02 | $-5.89 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | 10.7 |
| Quick Ratio | · | · | · | · | 0.8 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | · | · | $-24M |
Institutional owners (13F) 62 filers · $43.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
62
Value held
$43.7M
New positions
19
Exited positions
6
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 19 (+9 vs prior Q) | 6 (-3 vs prior Q) | 18 (+4 vs prior Q) | 3 (-1 vs prior Q) | +29.3M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Voss Capital, LP | $5,472,398 | 5,261,921 | 12.53% | Shares |
| Cable Car Capital, LP | $5,402,800 | 5,195,000 | 12.37% | Shares |
| ADAR1 Capital Management, LLC | $4,680,000 | 4,500,000 | 10.71% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $3,513,026 | 3,377,910 | 8.04% | Shares |
| BIOS Capital Management, LP | $3,101,670 | 2,982,375 | 7.10% | Shares |
| Ikarian Capital, LLC | $3,068,000 | 2,950,000 | 7.02% | Shares |
| GREAT POINT PARTNERS LLC | $2,678,000 | 2,575,000 | 6.13% | Shares |
| CITADEL ADVISORS LLC | $2,536,259 | 2,438,711 | 5.81% | Shares |
| Velan Capital Investment Management LP | $1,768,000 | 1,700,000 | 4.05% | Shares |
| VANGUARD GROUP INC | $1,352,336 | 1,165,807 | 3.10% | Shares |
| Senvest Management, LLC | $1,280,131 | 1,230,895 | 2.93% | Shares |
| Prosight Management, LP | $1,144,000 | 1,100,000 | 2.62% | Shares |
| Bleichroeder LP | $1,040,000 | 1,000,000 | 2.38% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $925,028 | 889,450 | 2.12% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $762,540 | 733,139 | 1.75% | Shares |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | $532,074 | 511,610 | 1.22% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $397,816 | 382,515 | 0.91% | Shares |
| STATE STREET CORP | $394,788 | 379,604 | 0.90% | Shares |
| Empery Asset Management, LP | $385,667 | 370,834 | 0.88% | Shares |
| Sigma Planning Corp | $367,824 | 353,677 | 0.84% | Shares |
| BlackRock, Inc. | $339,253 | 326,204 | 0.78% | Shares |
| Texas Capital Bank Wealth Management Services Inc | $312,789 | 300,758 | 0.72% | Shares |
| Sequoia Financial Advisors, LLC | $260,000 | 250,000 | 0.60% | Shares |
| GAGNON SECURITIES LLC | $238,233 | 229,070 | 0.55% | Shares |
| Stonepine Capital Management, LLC | $226,760 | 218,038 | 0.52% | Shares |
| Palogic Value Management, L.P. | $187,200 | 180,000 | 0.43% | Shares |
| NORTHERN TRUST CORP | $166,109 | 159,720 | 0.38% | Shares |
| ABS Direct Equity Fund LLC | $130,000 | 125,000 | 0.30% | Shares |
| Rock Creek Group LLC | $130,000 | 125,000 | 0.30% | Shares |
| Warberg Asset Management LLC | $100,980 | 99,000 | 0.23% | Shares |
| CORSAIR CAPITAL MANAGEMENT, L.P. | $83,200 | 80,000 | 0.19% | Shares |
| GOLDMAN SACHS GROUP INC | $82,976 | 79,785 | 0.19% | Shares |
| UBS Group AG | $59,706 | 57,410 | 0.14% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $52,479 | 50,461 | 0.12% | Shares |
| KCK LTD. | $52,055 | 22,341 | 0.12% | Shares |
| XTX Topco Ltd | $47,590 | 45,760 | 0.11% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $44,138 | 42,440 | 0.10% | Shares |
| Americana Partners, LLC | $43,514 | 41,840 | 0.10% | Shares |
| Prime Capital Investment Advisors, LLC | $37,555 | 36,111 | 0.09% | Shares |
| SteelPeak Wealth, LLC | $34,320 | 33,000 | 0.08% | Shares |
| Chicago Partners Investment Group LLC | $32,843 | 41,048 | 0.08% | Shares |
| Qube Research & Technologies Ltd | $32,018 | 30,787 | 0.07% | Shares |
| Meridian Wealth Advisors, LLC | $29,625 | 28,486 | 0.07% | Shares |
| Savant Capital, LLC | $23,315 | 30,528 | 0.05% | Shares |
| Gleason Group, Inc. | $23,285 | 22,389 | 0.05% | Shares |
| Global Retirement Partners, LLC | $20,089 | 19,316 | 0.05% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $19,760 | 19,000 | 0.05% | Shares |
| Cane Capital Partners, LLC | $18,720 | 18,000 | 0.04% | Shares |
| MORGAN STANLEY | $14,890 | 14,318 | 0.03% | Shares |
| Vanguard Global Advisers, LLC | $13,285 | 12,774 | 0.03% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Muneer A. Satter ×3 filings | April 16, 2024 | · | Initial filing | · | SEC |
| Muneer A. Satter (2) ×4 filings | Jan. 8, 2021 | · | Initial filing | · | SEC |
| Novartis Bioventures Ltd., Novartis AG ×7 filings | April 16, 2020 | · | Initial filing | · | SEC |
| Lilly Ventures Fund I, LLC, LV Management Group, LLC, S. Edward Torres, Steven E. Hall, Ph.D., Armen B. Shanafelt, Ph.D. ×2 filings | Aug. 13, 2019 | · | Initial filing | · | SEC |
| Excel Medical Fund, L.P., Excel Medical Ventures, LLC, Juan Enriquez, Frederick R. Blume, Steven R. Gullans | July 13, 2017 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 32 insiders · 10 officers · 17 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| James Brian Windsor | President and Chief Executive Officer | May 8, 2026 A | 27,046 | 1 | 0 | $25,000 |
| John P Longenecker PHD | President and CEO | Aug. 10, 2018 P | 10,000 | 0 | 0 | $0 |
| Joseph A., Yanchik III | President and Chief Executive Officer and Director | July 25, 2017 A | · | 0 | 0 | $0 |
| Rick Wanstall | Chief Financial Officer and Treasurer | March 30, 2022 A | · | 0 | 0 | $0 |
| Donald Dougherty | SVP & Chief Financial Officer | April 15, 2019 A | 5,000 | 0 | 0 | $0 |
| Allen Annis | SVP, Research | March 30, 2022 A | · | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | March 30, 2022 A | 75,000 | 0 | 0 | $0 |
| Satter Muneer A | In connection with its original investment, SMTP had a contractual right to designate one member of the Board of Directors of Ai | Jan. 8, 2021 P | 16,609,449 | 0 | 0 | $0 |
| Kathryn Gregory | SVP, Chief Business Officer | Jan. 31, 2020 A | 45,000 | 0 | 0 | $0 |
| Kira Nelson | Vice President, Finance and Operations | July 25, 2017 A | · | 0 | 0 | $0 |
| Josef H Von Rickenbach | Director | May 27, 2026 P | 62,514 | 4 | 0 | $49,701 |
| William Fairey | Director | July 23, 2025 A | · | 0 | 0 | $0 |
| Reinhard J. Ambros | Director | July 23, 2025 A | 5,800 | 0 | 0 | $0 |
| Manuel Aivado | Director | July 23, 2025 A | 1,000 | 0 | 0 | $0 |
| Alan A Musso | Director | July 23, 2025 A | · | 0 | 0 | $0 |
| Jodie Pope Morrison | Director | June 15, 2022 A | · | 0 | 0 | $0 |
| Jeffrey Allen Bailey | Director | June 15, 2022 A | 74,894 | 0 | 0 | $0 |
| Nolan Howard Sigal | Director | June 15, 2022 A | · | 0 | 0 | $0 |
| William Mckee | Director | June 15, 2022 A | · | 0 | 0 | $0 |
| John H Mcarthur | Director | June 19, 2019 A | · | 0 | 0 | $0 |
| Caleb Maxfield Winder | Director | June 21, 2018 A | · | 0 | 0 | $0 |
| Armen Shanafelt | Director | June 21, 2018 A | 1,094,987 | 0 | 0 | $0 |
| Brian M. Gallagher Jr. | Director | July 25, 2017 A | 1,431,519 | 0 | 0 | $0 |
| Scott Kapnick | Director | July 5, 2017 P | 66,666 | 0 | 0 | $0 |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 10% owner | June 17, 2024 S | 1,746,549 | 0 | 0 | $0 |
| Apple Tree Partners II - Annex, L.P. | 10% owner | July 6, 2018 J | 0 | 0 | 0 | $0 |
| APPLE TREE PARTNERS II LP | 10% owner | July 6, 2018 J | 0 | 0 | 0 | $0 |
| AJU IB Investment Co., Ltd. | 10% owner | July 5, 2017 C | 517,558 | 0 | 0 | $0 |
| Sigma Emerging Markets Ltd. | 10% owner | July 5, 2017 C | 423,086 | 0 | 0 | $0 |
| KCK LTD. | 10% owner | July 5, 2017 C | 646,817 | 0 | 0 | $0 |
| Jon B. Platt | 10% owner | July 5, 2017 C | 90,318 | 0 | 0 | $0 |
| CVF, LLC | 10% owner | July 5, 2017 C | 716,180 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
RNTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$6.00
+649.3%
2 22.2%
Strong Buy
5 55.6%
Buy
2 22.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-10-03Mean target $6.00 +649.3%
← Below all targets
Current price $0.80
Low$4.00
Mean$6.00
High$8.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| RNTX | · | -0.6 | · | · | · | · |
| RNXT | · | -2.6 | 2511.6% | · | · | · |
| ALDX | $312M | -9.2 | · | · | -68.0% | · |
| GRML | · | · | · | · | -104.9% | · |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | · |
| IBIO | $97M | -5.5 | -75.0% | -33044.0% | -65.7% | · |
| XBIT | · | -1.6 | · | · | · | · |
| APLM | · | -2.5 | · | -128.7% | -1305.4% | · |
| FBIO | · | · | · | · | · | · |
| NMAD | · | · | · | · | · | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026